Based in clinically important measures indicative of future morbidity and mortality risk, this technology—developed in the lab of Dr. Douglas Seals—predicts a person's biological age through a simple simple blood test.
Research teams led by Dr. Chris Lowry of CU Boulder and Dr. Thomas Keck of Rowan University are investigating the translational potential of a novel immunotherapy for its potential to reduce relapse-like and addictive behavior associated with cocaine use.
CU Boulder Assistant Professor Tam Vu and his team have developed a device called eBP to measure blood pressure from inside the user’s ear, aiming to minimize the measurement’s impact on users’ normal activities while maximizing its comfort level.
CU Boulder inventors Rong Yang and Yu (Jade) Morton developed a technology that uses the multi-frequency signals for a GNSS receiver (such as GPS) to improve performance of multi-frequency receivers in environments where signals on one or more frequency band experiences amplitude fading or phase fluctuation.
A low-cost, high-performance battery chemistry developed by CU Boulder researchers could one day lead to scalable grid-level storage for wind and solar energy that could help electrical utilities reduce their dependency on fossil fuels.
This method not only addresses the reduction of fossil fuel consumption in wastewater treatment, but also utilizes the wastewater as both a carbon sink and energy source for active CO2 mitigation from sources such as flue gas.
The Insider is Venture Partners at CU Boulder's monthly newsletter featuring the latest headlines, news, events, opportunities and emerging innovations coming out of the university. We have several editions for our audiences: